Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Remdesivir Use in Pediatric Patients with Acute SARS-CoV-2 Infection Is Safe and Well Tolerated.
Journal: Children (Basel, Switzerland)
Published: February 11, 2025
Safety and Efficacy of Ceftolozane/Tazobactam Versus Meropenem in Neonates and Children With Complicated Urinary Tract Infection, Including Pyelonephritis: A Phase 2, Randomized Clinical Trial.
Journal: The Pediatric infectious disease journal
Published: January 23, 2023
Use of COVID-19 Convalescent Plasma for Treatment of Symptomatic SARS-CoV-2 Infection at a Children's Hospital: A Contribution to a Still Inadequate Body of Evidence.
Journal: Children (Basel, Switzerland)
Published: December 01, 2022
Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial.
Journal: The Lancet. Child & adolescent health
Published: July 27, 2021
Safety and Antibody Kinetics of COVID-19 Convalescent Plasma for the Treatment of Moderate to Severe Cases of SARS-CoV-2 Infection in Pediatric Patients.
Journal: The Pediatric infectious disease journal
Published: May 10, 2021
Invasive Mycobacterium abscessus Outbreak at a Pediatric Dental Clinic.
Journal: Open forum infectious diseases
Published: January 29, 2021
High-grade heart block requiring transvenous pacing associated with multisystem inflammatory syndrome in children during the COVID-19 pandemic.
Journal: HeartRhythm case reports
Published: August 31, 2020
Multicentre validation of a computer-based tool for differentiation of acute Kawasaki disease from clinically similar febrile illnesses.
Journal: Archives of disease in childhood
Published: July 25, 2019
Safety and Tolerability of Clofazimine in a Cohort of Children With Odontogenic Mycobacterium abscessus Infection.
Journal: Journal of the Pediatric Infectious Diseases Society
Published: March 11, 2019
Blood Viral Load in Symptomatic Congenital Cytomegalovirus Infection.
Journal: The Journal of infectious diseases
Published: September 05, 2018
The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease.
Journal: Contemporary clinical trials
Published: August 27, 2018
High Risk of Coronary Artery Aneurysms in Infants Younger than 6 Months of Age with Kawasaki Disease.
Journal: The Journal of pediatrics
Published: October 20, 2016
Last Updated: 09/26/2026